Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Girindus, RiboTask Sign Commercial Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Girindus, RiboTask Sign Commercial Pact

Girindus signed a commercial collaboration agreement with RiboTask, a small-scale provider of oligonucleotides for use in R&D.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Girindus signed a commercial collaboration agreement with RiboTask, a small-scale provider of oligonucleotides for use in R&D. RiboTask will gain access to Girindus’ worldwide sales and marketing team and Girindus will have the ability to offer its customers seamless manufacture of a wide variety of oligonucleotides from the mg quantity to commercial kg quantities.

“Prof. Jesper Wengel, chairman of the board of RiboTask, has long been recognized as one of the leaders in the oligonucleotide field,” said Dr. Mark Laskovics, president and chief operating officer of Girindus America. “RiboTask has been built into a world-class organization to provide a range of oligonucleotides, particularly oligonucleotides possessing complex sequences. We are delighted that our two organizations will work together to provide the best possible solution for our customers.”

“We have seen in Girindus the technical and financial staying power to be the pre-eminent force in the oligonucleotide field,” stated Prof. Wengel. “We are delighted to enter into a partner relationship with Girindus.”


Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics